As of 2025-03-24, the Relative Valuation of Precision BioSciences Inc (DTIL) is 17.21 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.45 USD, the upside of Precision BioSciences Inc based on Relative Valuation is 215.8%.
The range of the Relative Valuation is 12.20 - 28.83 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 26.4x | 16.3x |
| Forward P/E multiples | 11.2x - 23.0x | 15.2x |
| Fair Price | 12.20 - 28.83 | 17.21 |
| Upside | 123.8% - 429.0% | 215.8% |
| Date | P/E |
| 2025-03-21 | 4.99 |
| 2025-03-20 | 4.90 |
| 2025-03-19 | 4.58 |
| 2025-03-18 | 4.56 |
| 2025-03-17 | 4.62 |
| 2025-03-14 | 4.61 |
| 2025-03-13 | 4.62 |
| 2025-03-12 | 4.63 |
| 2025-03-11 | 4.58 |
| 2025-03-10 | 4.67 |
| 2025-03-07 | 4.74 |
| 2025-03-06 | 4.71 |
| 2025-03-05 | 4.79 |
| 2025-03-04 | 4.66 |
| 2025-03-03 | 4.57 |
| 2025-02-28 | 4.93 |
| 2025-02-27 | 5.02 |
| 2025-02-26 | 5.04 |
| 2025-02-25 | 5.01 |
| 2025-02-24 | 5.15 |
| 2025-02-21 | 5.43 |
| 2025-02-20 | 5.39 |
| 2025-02-19 | 5.17 |
| 2025-02-18 | 4.71 |
| 2025-02-14 | 4.82 |
| 2025-02-13 | 4.63 |
| 2025-02-12 | 4.64 |
| 2025-02-11 | 4.47 |
| 2025-02-10 | 4.38 |
| 2025-02-07 | 4.30 |
| 2025-02-06 | 4.47 |
| 2025-02-05 | 4.52 |
| 2025-02-04 | 4.58 |
| 2025-02-03 | 4.27 |
| 2025-01-31 | 4.58 |
| 2025-01-30 | 4.77 |
| 2025-01-29 | 4.49 |
| 2025-01-28 | 4.61 |
| 2025-01-27 | 4.60 |
| 2025-01-24 | 4.65 |
| 2025-01-23 | 4.57 |
| 2025-01-22 | 4.55 |
| 2025-01-21 | 4.17 |
| 2025-01-17 | 4.54 |
| 2025-01-16 | 4.32 |
| 2025-01-15 | 4.81 |
| 2025-01-14 | 4.92 |
| 2025-01-13 | 5.25 |
| 2025-01-10 | 5.22 |
| 2025-01-08 | 4.12 |